Roche

company

About

Roche is a pharmaceutical and diagnostics company that focuses on improving people’s lives.

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$5B
Industries
Biotechnology,Health Care,Health Diagnostics,Pharmaceutical
Founded date
Jan 15, 1896
Number Of Employee
10001 - max
Operating Status
Active
Stock Symbol
swx:ROG
Legal Name
F. Hoffmann-La Roche Ltd

Roche is a pharmaceutical and diagnostics company that focused on improving people’s lives. Roche is the owner of F. Hoffmann-La Roche Ltd.

Roche is a provider of in-vitro diagnostics and drugs for cancer and transplantation. It specializes in medicines for oncology, virology, inflammation, metabolism, CNS, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology. F. Hoffmann-La Roche Ltd. serves hospitals, research labs, private medical labs, practicing physicians, and patients.

Its products include cancer treatments, such as Avastin, Herceptin, and MabThera which are also effective in the treatment of rheumatoid arthritis, anemia, and osteoporosis. F. Hoffmann-La Roche Ltd. also conducts research and development as well as production related to molecular diagnostic reagents, test systems, and test kits. In addition, it provides automated instruments, software, consumables, and IT solutions used in in-vitro diagnostics and research.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$7.79B
Roche has raised a total of $7.79B in funding over 2 rounds. Their latest funding was raised on Aug 4, 2021 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 4, 2021 Post-IPO Equity $5B 1 SoftBank Detail
May 6, 2020 Post-IPO Equity $500K 1 SCALE AI Detail
Jan 1, 2010 Post-IPO Equity Detail
Mar 14, 2003 IPO Detail
May 8, 2001 Post-IPO Equity $2.79B 1 Novartis Detail

Investments

Number of Investments
Number of Lead Investments
17
4
Roche has made 17 investments. Their most recent investment was on Dec 8, 2022, when Metagood raised $5M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 8, 2022 Metagood
Pre-seed $5M Cryptocurrency
Jan 17, 2022 Wilder World
Series Unknown $30M 3D Technology
Jan 11, 2022 Freenome
Corporate Round $290M Biotechnology Yes
Dec 15, 2021 Forethought
Series C $65M Artificial Intelligence
Nov 16, 2021 Fireside
Seed $10M Broadcasting

Investors

Number of Lead Investors
Number of Investors
3
3
Roche is funded by 3 investors. SoftBank and SCALE AI are the most recent investors.
Investor Name Lead Investor Funding Round
SoftBank Yes Post-IPO Equity
SCALE AI Yes Post-IPO Equity
Novartis Yes Post-IPO Equity

Employee Profiles

Number of Employee Profiles
119
Roche has 119 current employee profiles, including Executive Severin Schwan
Executive
Executive
Board member
Board member
Executive

Exits

Roche has had 3 exits. Roche most notable exits include C4 Therapeutics ,   Flatiron Health

Date Company Name Exit Type Industry
Oct 1, 2020 C4 Therapeutics IPO Health Diagnostics Detail
Feb 15, 2018 Flatiron Health M&A Biotechnology Detail
Sep 12, 2014 Affimed IPO Biotechnology Detail

Acquisition

Roche has acquired 51 organizations. Their most recent acquisition was Syntex Corporation on May 3, 1994. They acquired Syntex Corporation for $5.30B.

Date Company Name
Industry Acquisition Type Price
Health Diagnostics acquisition $ 5.30B Detail
Biotechnology acquisition Detail
Biotechnology acquisition $ 11B Detail
Health Care acquisition Detail
Jul 19, 2005 Roche Glycart
Biotechnology acquisition Detail